Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Loss before Income Tax Income before income taxes consists of the following:
Year Ended
December 31, 2022 December 25, 2021 December 26, 2020
  (In millions)
U.S. $ 2,093  $ 3,528  $ 1,213 
Non-U.S. (895) 147  67 
Total pre-tax income including equity income in investee $ 1,198  $ 3,675  $ 1,280 
Provision (Benefit) for Income Taxes The income tax provision (benefit) consists of:
Year Ended
December 31, 2022 December 25, 2021 December 26, 2020
  (In millions)
Current:
U.S. federal $ 1,191  $ 112  $ — 
U.S. state and local 31  11 
Non-U.S. 161  82 
Total 1,383  205  13 
Deferred:
U.S. federal (1,365) 320  (1,193)
U.S. state and local (26) (7) (28)
Non-U.S. (114) (5) (2)
Total (1,505) 308  (1,223)
Income tax provision (benefit) $ (122) $ 513  $ (1,210)
Schedule of Effective Income Tax Rate Reconciliation
The table below displays the reconciliation between statutory federal income taxes and the total income tax provision (benefit).
Year Ended
December 31, 2022 December 25, 2021 December 26, 2020
  (In millions)
Statutory federal income tax expense at 21% $ 252  $ 772  $ 269 
State taxes (benefit) (3) (6)
Foreign rate detriment (benefit) 195  71  (3)
GILTI and other foreign inclusion (105) —  — 
Foreign-Derived Intangible Income (FDII) deduction (261) (147) — 
Research credits (241) (78) (57)
Stock-based and non-deductible compensation 10  (125) (116)
Valuation allowance change —  (1,301)
Other 31  16 
Income tax provision (benefit) $ (122) $ 513  $ (1,210)
Schedule of Deferred Tax Assets and Liabilities
Deferred income taxes reflect the net tax effects of tax carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the balances for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2022 and December 25, 2021 were as follows:
December 31,
2022
December 25,
2021
  (In millions)
Deferred tax assets:
Net operating loss carryovers $ 1,031  $ 920 
Accruals and reserves not currently deductible 835  631 
Employee benefits not currently deductible 214  164 
Federal and state tax credit carryovers 631  319 
Foreign R&D and investment tax credits 578  547 
Capitalized costs 65  121 
Lease liability 161  124 
Capitalized R&D 943  — 
Other 85  27 
Total deferred tax assets 4,543  2,853 
Less: valuation allowance (2,078) (1,735)
Total deferred tax assets, net of valuation allowance 2,465  1,118 
Deferred tax liabilities:
Acquired intangibles (3,430) (50)
Right-of-use assets (151) (110)
Undistributed foreign earnings (35) (24)
GILTI (633) — 
Other (92) (15)
Total deferred tax liabilities (4,341) (199)
Net deferred tax assets (liabilities) $ (1,876) $ 919 
As a result of the acquisition of Xilinx, the Company recorded $4.3 billion of net deferred tax liabilities primarily on the excess of book basis over the tax basis of the acquired intangible assets, including $857 million of GILTI net deferred tax liability.
Additionally, as the result of the new R&D capitalization tax law effective in 2022, the capitalized amounts resulted in increased current year taxable income, but which are deductible as amortized in future periods. Therefore, the Company recorded a deferred tax asset for the capitalized R&D expenditures.
The movement in the deferred tax valuation allowance was as follows:
December 31, 2022 December 25, 2021 December 26, 2020
  (In millions)
Balance at beginning of year $ 1,735  $ 1,576  $ 2,867 
Charges (reductions) to income tax expense and other accounts* 112  (1,301)
Acquisition-related 231  —  — 
Net recoveries+
—  156  10 
Balance at end of year $ 2,078  $ 1,735  $ 1,576 
*
Amounts recorded in 2020 reflect release of valuation allowances.
+ The net recoveries for all were primarily related to net originating deferred tax assets and newly generated tax credits.
Under current U.S. tax law, the impact of future distributions of undistributed earnings that are indefinitely reinvested are anticipated to be subject to withholding taxes from local jurisdictions and non-conforming U.S. state jurisdictions. The amount of cumulative undistributed earnings that are permanently reinvested that could be subject to withholding taxes are $460 million as of December 31, 2022.
Schedule of Unrecognized Tax Benefits Roll Forward reconciliation of the Company's gross unrecognized tax benefits was as follows:
December 31, 2022 December 25, 2021 December 26, 2020
  (In millions)
Balance at beginning of year $ 275  $ 119  $ 65 
Increases for tax positions taken in the current year 748  156  30 
Increases for tax positions taken in prior years 104  14  41 
Decreases for tax positions taken in prior years (12) (9) (15)
Increases to tax positions taken in prior years through acquisitions 252  —  — 
Decreases for settlements with taxing authorities and statute of limitation lapses (6) (5) (2)
Balance at end of year $ 1,361  $ 275  $ 119